Aclaris Therapeutics, Inc. (ACRS)

PetIQ Revenue

Aclaris Therapeutics had revenue of $1.78M in the quarter ending June 30, 2025, a decrease of -35.76%. This brings the company's revenue in the last twelve months to $16.79M, down -47.56% year-over-year. In the year 2024, Aclaris Therapeutics had annual revenue of $18.72M, down -40.09%.

• Revenue (ttm): $16.79M
• Revenue Growth: -47.56%
• P/S Ratio: 9.63
• Revenue / Employee: $262,328
• Employees: 64
• Market Cap: 174.87M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	18.72M	-12.53M	-40.09%
Dec 31, 2023	31.25M	1.50M	5.03%
Dec 31, 2022	29.75M	22.99M	340.05%
Dec 31, 2021	6.76M	279.00K	4.30%
Dec 31, 2020	6.48M	2.26M	53.35%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.